Article
Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: application to the evaluation of CYP2D6 genotype and debrisoquine metabolic ratio relationship.
Clinical chemistry and laboratory medicine - 1 Jan 2005
Dorado Pedro, Berecz Roland, Cáceres Macarena C, González Idilio, Cobaleda Jesús, Llerena Adrián
Abstract excerpt
The drug-metabolizing cytochrome P450 (CYP) enzyme CYP2D6 is involved in the metabolism of several clinically important drugs. So far more than 50 different CYP2D6 allelic variants have been described, and thus there is an increased need for routine high-performance liquid chromatography (HPLC) methods for the evaluation of the functional implication of CYP2D6 polymorphism. Debrisoquine is metabolized to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.